Oppenheimer & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.16M | Buy |
+39,422
| New | +$3.25M | 0.04% | 455 |
|
|
2025
Q4 | – | Sell |
-81,782
| Closed | -$6.36M | – | 1633 |
|
|
2025
Q3 | $6.36M | Buy |
81,782
+7,141
| +10% | +$558K | 0.08% | 281 |
|
|
2025
Q2 | $5.84M | Buy |
74,641
+8,747
| +13% | +$652K | 0.08% | 279 |
|
|
2025
Q1 | $4.78M | Buy |
65,894
+5,853
| +10% | +$419K | 0.07% | 302 |
|
|
2024
Q4 | $4.44M | Buy |
60,041
+21,855
| +57% | +$1.53M | 0.07% | 318 |
|
|
2024
Q3 | $2.52M | Buy |
38,186
+1,441
| +4% | +$105K | 0.04% | 478 |
|
|
2024
Q2 | $3.39M | Buy |
36,745
+10,492
| +40% | +$929K | 0.05% | 368 |
|
|
2024
Q1 | $2.51M | Buy |
26,253
+4,977
| +23% | +$418K | 0.04% | 447 |
|
|
2023
Q4 | $1.62M | Sell |
21,276
-10,813
| -34% | -$752K | 0.03% | 559 |
|
|
2023
Q3 | $2.22M | Sell |
32,089
-6,463
| -17% | -$519K | 0.05% | 427 |
|
|
2023
Q2 | $3.64M | Sell |
38,552
-1,050
| -3% | -$91.3K | 0.07% | 299 |
|
|
2023
Q1 | $3.28M | Sell |
39,602
-18,758
| -32% | -$1.47M | 0.07% | 314 |
|
|
2022
Q4 | $4.35M | Buy |
58,360
+14,635
| +33% | +$1.13M | 0.1% | 249 |
|
|
2022
Q3 | $3.61M | Sell |
43,725
-1,608
| -4% | -$155K | 0.08% | 287 |
|
|
2022
Q2 | $4.31M | Buy |
45,333
+2,202
| +5% | +$228K | 0.09% | 261 |
|
|
2022
Q1 | $5.08M | Sell |
43,131
-1,118
| -3% | -$125K | 0.09% | 274 |
|
|
2021
Q4 | $5.73M | Buy |
44,249
+1,826
| +4% | +$213K | 0.1% | 233 |
|
|
2021
Q3 | $4.8M | Buy |
42,423
+1,970
| +5% | +$225K | 0.09% | 262 |
|
|
2021
Q2 | $4.19M | Sell |
40,453
-4,257
| -10% | -$401K | 0.08% | 308 |
|
|
2021
Q1 | $3.74M | Sell |
44,710
-13,309
| -23% | -$1.13M | 0.07% | 309 |
|
|
2020
Q4 | $5.29M | Sell |
58,019
-3,624
| -6% | -$301K | 0.11% | 209 |
|
|
2020
Q3 | $4.92M | Buy |
61,643
+12,632
| +26% | +$986K | 0.12% | 185 |
|
|
2020
Q2 | $3.39M | Sell |
49,011
-11,049
| -18% | -$785K | 0.09% | 255 |
|
|
2020
Q1 | $3.78M | Buy |
60,060
+22,770
| +61% | +$1.64M | 0.11% | 192 |
|
|
2019
Q4 | $2.9M | Buy |
37,290
+7,059
| +23% | +$551K | 0.07% | 307 |
|
|
2019
Q3 | $2.22M | Sell |
30,231
-5,451
| -15% | -$383K | 0.06% | 375 |
|
|
2019
Q2 | $2.2M | Sell |
35,682
-16,698
| -32% | -$1.01M | 0.06% | 368 |
|
|
2019
Q1 | $3.34M | Sell |
52,380
-2,547
| -5% | -$145K | 0.09% | 259 |
|
|
2018
Q4 | $2.8M | Buy |
54,927
+4,284
| +8% | +$217K | 0.09% | 261 |
|
|
2018
Q3 | $2.94M | Buy |
50,643
+9,972
| +25% | +$488K | 0.07% | 294 |
|
|
2018
Q2 | $1.97M | Sell |
40,671
-18,114
| -31% | -$845K | 0.05% | 395 |
|
|
2018
Q1 | $2.73M | Sell |
58,785
-1,338
| -2% | -$58.1K | 0.07% | 318 |
|
|
2017
Q4 | $2.26M | Buy |
60,123
+30,573
| +103% | +$1.12M | 0.06% | 354 |
|
|
2017
Q3 | $1.08M | Sell |
29,550
-21,138
| -42% | -$806K | 0.03% | 589 |
|
|
2017
Q2 | $2M | Sell |
50,688
-2,703
| -5% | -$98.7K | 0.06% | 390 |
|
|
2017
Q1 | $1.67M | Sell |
53,391
-7,791
| -13% | -$244K | 0.05% | 436 |
|
|
2016
Q4 | $1.91M | Sell |
61,182
-124,134
| -67% | -$4.02M | 0.06% | 388 |
|
|
2016
Q3 | $7.45M | Sell |
185,316
-22,740
| -11% | -$856K | 0.22% | 102 |
|
|
2016
Q2 | $6.92M | Buy |
208,056
+5,898
| +3% | +$202K | 0.21% | 105 |
|
|
2016
Q1 | $5.94M | Buy |
202,158
+131,541
| +186% | +$3.63M | 0.18% | 124 |
|
|
2015
Q4 | $1.86M | Buy |
70,617
+19,317
| +38% | +$502K | 0.06% | 373 |
|
|
2015
Q3 | $1.22M | Buy |
51,300
+6,048
| +13% | +$146K | 0.04% | 509 |
|
|
2015
Q2 | $1.07M | Sell |
45,252
-108
| -0.2% | -$2.44K | 0.03% | 606 |
|
|
2015
Q1 | $1.08M | Buy |
45,360
+504
| +1% | +$11.3K | 0.03% | 607 |
|
|
2014
Q4 | $953K | Buy |
44,856
+13,722
| +44% | +$276K | 0.03% | 620 |
|
|
2014
Q3 | $530K | Sell |
31,134
-288
| -0.9% | -$4.55K | 0.02% | 828 |
|
|
2014
Q2 | $450K | Sell |
31,422
-13,248
| -30% | -$180K | 0.01% | 890 |
|
|
2014
Q1 | $552K | Sell |
44,670
-32,946
| -42% | -$380K | 0.02% | 789 |
|
|
2013
Q4 | $850K | Buy |
77,616
+3,264
| +4% | +$36.8K | 0.03% | 618 |
|
|
2013
Q3 | $863K | Buy |
+74,352
| New | +$870K | 0.03% | 592 |
|
Other funds holding EW
VCM
VPM
Oppenheimer & Co's EW Position: Q1 2026 in Review
Oppenheimer & Co opened a new position in Edwards Lifesciences (EW) in Q1 2026: 39,422 shares worth $3.16M. The stake represents 0.04% of the portfolio and ranks #455 among its holdings. This is a return to the name: Oppenheimer & Co previously reported a position in EW as recently as Q3 2025.
Oppenheimer & Co first reported a position in EW in Q3 2013 and has held it in 50 quarters since. The position peaked at $7.45M in Q3 2016. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Oppenheimer & Co held 39,422 shares of Edwards Lifesciences worth $3.16M as of Q1 2026.
- Edwards Lifesciences was a new Oppenheimer & Co position in Q1 2026.
- Edwards Lifesciences made up 0.04% of Oppenheimer & Co's portfolio in Q1 2026, its #455 holding.
- Oppenheimer & Co first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 50 quarters since.
- Oppenheimer & Co's Edwards Lifesciences position peaked at $7.45M in Q3 2016.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.